Table 2.
Descriptive statistics for colostrum IgG quantity and microbiological quality stratified by treatment group from a randomized clinical trial evaluating the effects of oligosaccharide supplementation on serum IgG concentration and apparent efficiency of IgG absorption in neonatal dairy calves
| Treatment Group | TPC log10 CFU/mL Mean (SD) | TCC log10 CFU/mL Mean (SD) | TEC log10 CFU/mL Mean (SD) | Colostrum IgG (g/L) Mean (SD) | Colostrum IgG Mass (g) Mean (SD) | N |
|---|---|---|---|---|---|---|
| MOS | 4.6 (1.2) | 2.9 (1.7) | 3.3 (2.1) | 72.09 (19.86) | 264.91 (76.25) | 33 |
| SGOS | 4.6 (1.1) | 2.6 (1.8) | 3.0 (2.2) | 72.74 (21.58) | 268.96 (74.96) | 31 |
| BGOS | 4.7 (1.1) | 3.8 (1.5) | 3.0 (1.9) | 80.05 (20.84) | 294.04 (78.84) | 28 |
| CON | 4.5 (0.70) | 3.1 (1.3) | 3.0 (1.9) | 74.93 (16.69) | 270.63 (61.48) | 31 |
| All samples | 4.6 (1.1) | 3.1 (1.6) | 3.1 (2.0) | 74.78 (19.80) | 274.00 (73.05) | 123 |
| P | .75 | .27 | .86 | .41 | .42 |
MOS = Mannan‐oligosaccharides; SGOS = Saccharomyces galacto‐oligosaccharides; BGOS = Bifidobacterium galacto‐oligosaccharides, and CON = lactose control; TPC = total plate count; TCC = total coliform count; TEC = total E. coli count; P = P‐value for statistical significance for differences among treatment groups.